Icon
+91 94997 68112
Login Register

Ryzolt - (100 mg, 200 mg, 300 mg;Tablet, Extended Release)

Tramadol Hydrochloride Purdue
100 mg, 200 mg, 300 mg;Tablet, Extended Release
Less Than $1000 mn
Less Than 5
Less Than 5
None None
Less Than 5
Less Than 5
Ryzolt is indicated for the management of moderate to moderately severe chronic pain in adults who require around-the-clock treatment of their pain for an extended period of time.
Yes
*** ** *** ***** ** **** **** ** **** ****** *** ****** *** (******** ** *** **, ****) & *** (*** ** ******). ******** ***** ***** **** *** ******* ** ******* & ******* ******* ******** *** ********. *******, ****** *** **(*** *******) *********** **** ****** **** ******** ***** ******** ** ***'* **** ***** *** *********** ****** ******* ** ******** **, ****. ***** ****** ***** * **** ** ** ****** *** (*** **-****** ** ****), *** (*** **- ****** ** ****) & ****** *** (******** ** **** **, ****) *** *** ********* **** *** ******* *** & ***. ****** ******* ** ******** ****** ***. ******* *** ***** ***** ** ***** ** ****** ** ********* ****** *** & *** ** *******. ****** ***** * ****** *** *********** ******** ********* ********** ** *** ************ ** ****** *** ** ****** *** *** ******* ****** ******* ***** *** ******. ** *** ****** *** ** *********** (** ****** *** ******* ** ***** *** ****), *** **** ** **** ** ****** **** *** **, **** *.* ***** *** *** ******* *********** ******.
Ryzolt Patent 1 Patent 2 Patent 3
*** ****** *** ********* *** ** ** *** ** **
****** *** ********* *** ********* *** *********
Company FTF Status / 180 days exclusivity 30-Months stay Current Litigation Status Current Approval Status Likelihood of launch
*** ****** *** \ ** *** *, **** *** ** ** ******** ******** ** *** **, ****
****** ** \ ** ** *** ********* ******** *** ****** *** ****
  1. ********* **, **** : *** ******** ****** ***** *** **** *** **** ** ****** **** ****** ** ******* *******, *******.
  2. ******** *,**** : ****** ***** * **** ******* *** *** *** **** ** ****** ** *** ******** ***** ** ********.
  3. ******* **, **** : ******** ***** ***** ** ****** ** *** ********* *** ******* *******, ******* ** ** ******* ** *** ******* ** ***********.****** *** * *** ****** **** ****** *********** ****** **** ******** ***** ******** ** ***'* **** ***** *** *********** ****** ******* ** ******** **, ****.
  4. ******** **, **** : ****** ******** ****** ***** *** **** *** **** ** ****** **** ****** ** ****** ** '***, '***, '***.
  5. ******* **, **** : ****** ****** ******** *.*. *** **** *************** ***** ***. ***** * ******* ******* ****** ** *** ****** ****** ******** ***** *** *** ******* ******** ** ********** ******** ******** **** ******,* **** ** ****** *** ****** ** '*** *** '***. ****** ******* ** **** * **** *** ****** ***.
  6. ********* **, **** : ****** ***** * ****** ** *********** ********* ********* ********** ** ***-************ ** ****** *** (*** ***** ** *** *** *********).

Download ParaIV Report

Download ParaIV Detailed Report

To get detailed report Contact Us

ParaIV Advanced Search






Please contact contact@researchdelta.com to get more details.

Headquarters

Research Delta Advisor, G4,Sani Apartment, Bank of india lane, Ellora park, Vadodara 390023

+91 94997 68112

nimish@researchdelta.com

Products & Services

Para IV GenUS Pharmalysis Consulting Valuation

Quick Links

Home About Career Media Coverage Contact
© Research Delta, All Right Reserved.